• 28:00 - 30:50
47: Killer Wasp
Shaving Vaccine Development Timelines and Testing in Vulnerable Communities
The typical 3-to-12-year timeline for vaccine development was significantly shortened for COVID-19 through government pre-financing. Concerns are raised about testing these new technologies on vulnerable populations in Africa and urban American centers. Historical precedents like the Tuskegee experiment are cited as reasons for deep-seated apprehension regarding rapid medical rollouts.